跳至主要内容
临床试验/NL-OMON54080
NL-OMON54080招募中3 期

ltrasound-guided Radiofrequency Ablation versus radioactive iodine as Treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid Nodules - RABITO study

Rijnstate Ziekenhuis0 个研究点目标入组 232 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
232

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age > 18 years
  • - Hyperthyroidism or subclinical hyperthyroidims caused by a solitary
  • hyperactive thyroid nodule (HTN), either located in an otherwise normal thyroid
  • gland, or in a multinodular goitre (MNG)
  • - Treatment with RAI indicated and eligible for RFA
  • - Signed informed consent

排除标准

  • - Multifocal HTN
  • - HTN > 50 mm
  • - Presence of a medical device susceptible to disturbances caused by RFA
  • generated currents
  • - Patients with physical or behavioural disorders that preclude safe isolation
  • in radiation protection rooms, or safe RFA procedure under local anesthesia
  • - Uncorrectable hemorrhagic diathesis
  • - Pregnancy

研究者

发起方
Rijnstate Ziekenhuis

相似试验